Kaneh Bosm Biotechnology Inc Share Price Canadian Securities Exchange
Equities
CA4841902022
Drug Retailers
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.32Cr 1.81Cr 110.39Cr |
---|---|---|---|---|---|
Net income 2018 | - 0 0 | Net income 2019 | -6Cr -8.19Cr -500.65Cr | EV / Sales 2018 * | - |
Net cash position 2018 * | - 0 0 | Net cash position 2019 * | - 0 0 | EV / Sales 2019 * | - |
P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15/19/15 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27/18/27 |
Corporate Officer/Principal | - | 25/19/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27/18/27 |
Matthew Fish
BRD | Director/Board Member | - | 29/19/29 |
1st Jan change | Capi. | |
---|---|---|
+15.20% | 297.63Cr | |
-14.63% | 127.38Cr | |
+58.99% | 54Cr | |
-7.27% | 44Cr | |
-2.51% | 9.36Cr | |
-29.77% | 7.34Cr | |
+34.83% | 5.46Cr |